• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: APOLLO ENDOSURGERY, INC. ORBERA® INTRAGASTRIC BALLOON SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

APOLLO ENDOSURGERY, INC. ORBERA® INTRAGASTRIC BALLOON SYSTEM Back to Search Results
Model Number B-50000
Device Problem Detachment of Device or Device Component (2907)
Patient Problem No Code Available (3191)
Event Date 10/28/2019
Event Type  malfunction  
Manufacturer Narrative
Medwatch submitted to the fda.Apollo has not received the product at this time.Therefore no analysis or testing has been done.A review of the device labeling notes the following: the current orbera® intragastric balloon system directions for use (dfu) addresses the known and anticipated potential event of "difficulty with fill tube" as follows: "precautions: if difficulty with the orbera® fill tube is noted during placement (e.G., resistance to balloon filling), then the device should be removed and replaced with a new balloon.To lessen, or prevent fill tube defects, during the filling process the fill tube must remain slack.If the fill tube is under tension during this process, the fill tube may dislodge from the balloon, preventing further balloon deployment." "warnings: when filling the balloon during the placement procedure, avoid rapid fill rates as these will generate high pressure which can damage the orbera® valve or cause premature detachment of the balloon from the placement catheter." "orbera® is composed of a soft silicone elastomer and is easily damaged by instruments or sharp objects.The balloon must be handled only with gloved hands and with the instruments recommended for removal." "caution: if the balloon becomes separated from the sheath prior to placement, do not attempt to use the balloon or reinsert the balloon into the sheath." "caution: during the filling process the fill tube must remain slack.If the fill tube is under tension during this process the fill tube may dislodge from the balloon preventing further balloon deployment." "warning: rapid fill rates will generate high pressure which can damage the orbera® valve or cause premature detachment." the labeling is adequate as it addresses the reported complaint.The occurrence of this reported complaint for this product will be reviewed in the next complaints analysis meeting (cam).
 
Event Description
Health professional reported via product field notes (pfn), "at the time of balloon placement, the balloon had disconnected between the valve and the catheter.".
 
Manufacturer Narrative
Supplement #1-medwatch submitted to the fda on 31/mar/2020.Additional information: d10, h3, h6, h10.Device evaluation summary: the device was returned to the apollo device analysis laboratory on 6/march/2020.Received one non-inflated balloon with the fill tube disconnected from the slit valve.The sheath is still present and there is no liquid inside balloon.The fill tube tip was reinserted into the slit valve for testing.The end of the balloon was clamped onto the pull force equipment and met minimum requirements.The fill tip pressure to inflate the balloon met minimum requirements as well.The balloon was fully inflated, and the sheath broke away as intended.The inflated balloon was then submerged in liquid and there were no leaks/holes in the shell.A pin gauge was used to check the circumference of the fill tube tip and met requirement.The complaint was verified as the fill tube was disconnected from the slit valve upon receiving of the device; however, once reinserted the device performed as intended.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORBERA® INTRAGASTRIC BALLOON SYSTEM
Type of Device
INTRAGASTRIC BALLOON
Manufacturer (Section D)
APOLLO ENDOSURGERY, INC.
1120 s. capital of texas hwy
bldg 1, ste. 300
austin TX 78746
MDR Report Key9447412
MDR Text Key183977539
Report Number3006722112-2019-00192
Device Sequence Number1
Product Code LTI
Combination Product (y/n)N
PMA/PMN Number
P140008
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 03/18/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/10/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/19/2021
Device Model NumberB-50000
Device Catalogue NumberB-50000
Device Lot NumberAF02990
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/06/2020
Date Manufacturer Received03/06/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age44 YR
Patient Weight85
-
-